Table 3.
Clinical features and management of COVID-19 infection for all cases and hospitalised cases
| Variable | All cases (n=405) | Hospitalised patients | |
| Children (n=44) | Adults (n=74) | ||
| Symptoms prior to hospital admission, n (%) | |||
| Shortness of breath | 88 (21.7) | 21 (47.7) | 22 (29.7) |
| Coryza | 97 (24.0) | 15 (34.1) | 15 (20.3) |
| Anosmia | 46 (11.4) | 0 (0.0) | 3 (4.1) |
| Chest Pain | 16 (4.0) | 0 (0.0) | 3 (4.1) |
| Asymptomatic | 75 (18.5) | 10 (22.7) | 5 (6.8) |
| Missing | 0 (0.0) | 0 (0.0) | 0 (0.0) |
| Medications administered, n (%) | |||
| Intravenous antibiotics | 43 (10.6) | 27 (61.4) | 14 (18.9) |
| Antivirals | 9 (2.2) | 9 (20.5) | 0 (0.0) |
| Steroids | 19 (4.7) | 8 (18.2) | 10 (13.5) |
| Immunoglobulin | 2 (0.5) | 2 (4.5) | 0 (0.0) |
| Missing | 308 (76.0) | 2 (4.5) | 50 (6.8) |
| Respiratory support in hospital, n (%) | |||
| Oxygen | 28 (6.9) | 10 (22.7) | 8 (10.8) |
| High flow oxygen | 6 (1.5) | 5 (11.4) | 1 (1.4) |
| Non-invasive ventilation | 3 (0.7) | 3 (6.8) | 0 (0.0) |
| Intubation and ventilation | 12 (3.0) | 11 (25.0) | 1 (1.4) |
| Nitric oxide | 2 (0.5) | 2 (4.6) | 0 (0.0) |
| Missing | 276 (68.1) | 1 (2.3) | 50 (67.6) |
| Circulatory support in hospital, n (%) | |||
| Inotropes | 9 (2.2) | 8 (18.2) | 1 (1.4) |
| Extra-corporeal membrane oxygenation | 1 (0.3) | 1 (2.3) | 0 (0.0) |
| Missing | 312 (77.0) | 1 (2.3) | 55 (74.3) |
| Death within 28 days of COVID-19, n (%) | |||
| Yes | 29 (7.1) | 5 (11.4) | 17 (23.0) |
| No | 361 (88.9) | 39 (88.6) | 48 (64.9) |
| Missing | 16 (3.9) | 0 (0.0) | 9 (12.2) |
| Length of hospital stay (days), median (IQR) | |||
| 7 (4-30) | 8 (4-18) | ||
| Missing n (%) | 9 (20.5) | 41 (55.4) | |